Abbott Launches Molecular Point-of-Care Test to Detect Novel Coronavirus in as Little as Five Minutes
COVID-19 Update and Capabilities From ImmunoChemistry Technologies
For the Record with Dave Hemink, Chief Executive Officer, Nonin Medical
At The Table – March 27, 2020